FILE:CVH/CVH-8K-20080618161357.txt.gz
EVENTS:	Regulation FD Disclosure	Financial Statements and Exhibits
TEXT:
ITEM: Regulation FD Disclosure
ITEM: Financial Statements and Exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported)
June 18, 2008
 
 
COVENTRY HEALTH CARE, INC.
(Exact name of registrant as specified in its charter).
 
 
 
6705 Rockledge Drive, Suite 900, Bethesda, Maryland 20817
(Address of principal executive offices) (Zip Code)
 
(301) 581-0600
(Registrant's telephone number, including area code)
 
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
 
Precommencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
 
Precommencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
SECTION 7 
Regulation FD
 
ITEM 7.01 
Regulation FD Disclosure
 
On June 18, 2008, Coventry Health Care, Inc. ("the Company") issued a news release stating that the Company has updated its publicly disclosed financial expectations for the second quarter and full fiscal year 2008. A copy of the news release is furnished herewith as Exhibit 99.1. The exhibit is not deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 or incorporated by reference in the Company's filings under the Securities Exchange Act of 1933.
 
SECTION 9  FINANCIAL STATEMENT AND EXHIBITS
 
ITEM 9.01  Financial Statements and Exhibits
 
 
 
 
 
 
Signature
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
 
 
Exhibit Index
 
 
 
 
 

 
 
Exhibit 99.1
 
 
6705 Rockledge Drive, Suite 900
Bethesda, MD 20817-1850
(301) 581-0600
Chief Financial Officer
(301) 581-5701
 
Drew Asher
Senior Vice President, Corporate Finance
(301) 581-5717
 
Coventry Health Care Revises 2008 Outlook
 
BETHESDA, Md. (June 18, 2008) - Coventry Health Care, Inc. (NYSE: CVH) today reported a revised operating outlook for 2008, reducing second quarter and full year 2008 earnings per share estimates. Based upon trends that have been observed during the second quarter, as detailed below, the Company expects second quarter diluted earnings per share (EPS) in the range of $0.55 to $0.57 and full year diluted EPS in the range of $3.65 to $3.75.
 
"We are very disappointed with the April and May 2008 results and their anticipated effect on the second quarter and the full year," said Dale B. Wolf, chief executive officer of Coventry. "We have implemented corrective actions that we anticipate will put us back on an acceptable EPS growth path for 2009 and beyond."
 
Based upon a review of each line of business, the Company has observed and quantified the following developments contributing to the revised expectations and guidance:
 
 
 
Page 1 of 3
 
 
 
 
The following table summarizes the estimated impact of these items as measured against the midpoint of previously provided Company guidance:
 
 
 
 
The Company has provided a revised 2008 forecast including the changes referenced above:
 
Consolidated Guidance Details
 
2008 Quarterly Guidance
 
 
2008 Full Year Guidance
 
 
Page 2 of 3
 
 
 
 
Mr. Wolf will host a conference call at 5:30 p.m. ET on Wednesday, June 18, 2008. To listen to the call, dial toll-free at (888) 244-2488 or, for international callers, (913) 312-1389. Callers will be asked to identify themselves and their affiliations. The conference call will also be broadcast from Coventry's Investor Relations website at www.cvty.com. Coventry asks participants on both the call and webcast to review and be familiar with its filings with the Securities and Exchange Commission (SEC). A replay of the call will be available for one week at (888) 203-1112 or, for international callers, (719) 457-0820. The access code is 4672248. Additionally, the audio webcast will be available from Coventry's Investor Relations website for a period of 90 days following the call.
 
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are defined as statements that are not historical facts and include those statements relating to future events or future financial performance. Actual performance may be significantly impacted by certain risks and uncertainties, including those described in Coventry's Annual Report on Form 10-K for the year ended December 31, 2007 and Coventry's Form 10-Q for the quarter ended March 31, 2008. Coventry undertakes no obligation to update or revise any forward-looking statements.
 
Coventry Health Care (www.cvty.com) is a diversified national managed healthcare company based in Bethesda, Maryland, operating health plans, insurance companies, network rental and workers' compensation services companies. Through its Commercial Business, Individual Consumer & Government Business, and Specialty Business divisions, Coventry provides a full range of risk and fee-based managed care products and services to a broad cross section of individuals, employer and government-funded groups, government agencies, and other insurance carriers and administrators.
 
Page 3 of 3
 
 
 


